GS Labs hits BCBS of Minnesota with new antitrust lawsuit

Minneapolis-based GS Labs has filed new counterclaims in an ongoing legal fight against Blue Cross Blue Shield of Minnesota.

Advertisement

GS Labs alleged in 21 new counterclaims that the insurer violated antitrust laws and the CARES Act, conspired with other BCBS affiliates to fix prices and illegally boycott testing labs, and committed consumer fraud, according to a June 29 news release.

The lab said in the filing that BCBS Minnesota allegedly worked with other BCBS affiliates to set unsustainably high COVID-19 testing prices. The companies also allegedly conspired to boycott providers “that do not accede to the BCBS cartel’s fiat prices.”

GS Labs alleges in the counterclaims that BCBS Minnesota failed to pay tens of millions of dollars in COVID-19 test reimbursements. The lab is seeking full payment for those reimbursements, plus legal and investigative fees, compensation for lost goodwill, and three times the actual damages for each of the payer’s alleged antitrust violations.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Lab

Advertisement

Comments are closed.